Latest news with #CronosGroupInc.
Yahoo
22-04-2025
- Business
- Yahoo
Cronos Unveils New Spinach® 1.2g Vapes and SOURZ by Spinach® Gummies Enhanced with Rare Cannabinoids
TORONTO, April 22, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc.'s (NASDAQ: CRON) (TSX: CRON) ('Cronos' or the 'Company') best-selling cannabis brand, Spinach®, is thrilled to introduce three all-new 1.2g vape products, each expertly crafted with premium THC and enhanced with rare cannabinoids for a uniquely elevated experience. Along with these innovative vape offerings, Cronos is also unveiling new SOURZ by Spinach® Fully Blasted flavors, infused with rare cannabinoids. The new lineup includes three new 1.2 gram vapes in the following formats: Mango Kiwi Haze CBC (Sativa): A refreshing, uplifting blend with a 1:10 CBC-to-THC ratio. Peach Passionfruit Kush CBN (Indica): A dreamy, restful experience with a 1:10 CBN-to-THC ratio. Strawberry Watermelon OG CBG (Hybrid): A blissful, relaxed high with a 1:10 CBG-to-THC ratio. Designed for consumers who prioritize both potency and added value, these vapes deliver 1,000mg of THC without compromising on the unique benefits of rare cannabinoids. Each product features winterized, distilled cannabis extract for purity, combined with terpene-rich flavors inspired by renowned cultivars. All Spinach® vapes are crafted with ceramic heaters, stainless steel components, and food-grade materials to ensure quality and a smooth experience. In addition to the Spinach® vape launch, Cronos is expanding its best-selling edible line, SOURZ by Spinach®, with the new Fully Blasted lineup with each package containing one 10mg THC gummy in bold, fruit-forward flavors: Mango Lime: Tropical mango and tangy lime flavors with 10mg CBC and 10mg THC per gummy. Peach Passionfruit: Peach and exotic passionfruit flavors with a balanced ratio of 10mg CBN and 10mg THC per gummy. Strawberry Watermelon: Strawberry and refreshing watermelon flavors with 10mg CBG and 10mg THC per gummy. 'We are thrilled to expand our Spinach® 1.2g vape and SOURZ by Spinach® Fully Blasted lineups with these innovative products that combine THC potency and the added benefits of rare cannabinoids. This new lineup will deliver what so many consumers are looking for: mouthwatering flavors, rare cannabinoid enhancers, and THC,' said Mike Gorenstein, Chairman, President, and CEO of Cronos Group. 'Cronos is committed to delivering exceptional cannabis experiences that meet evolving consumer preferences. Our goal is to continually innovate and provide our adult consumers with high-quality, enjoyable cannabis experiences. These new flavors and formulations reflect our dedication to quality, innovation, and giving consumers more reasons to choose Spinach®.'The launch is backed by the brand's in-store trade marketing, with dedicated budtender education, digital placements, and enhanced point-of-purchase materials. For more information and availability, please visit: About Cronos Group Inc. Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos' diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: Forward-looking Statements This press release may contain information that may constitute 'forward-looking information' or 'forward-looking statements' within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, 'Forward-looking Statements'). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as 'may', 'will', 'expect', 'plan', 'anticipate', 'intend', 'potential', 'estimate', 'believe' or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about product launches and innovations and the consumer experience with respect thereto; and the Company's intention to build an international iconic brand portfolio and develop disruptive intellectual property by advancing cannabis research, technology and product development. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks. Financial results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, which has been filed on SEDAR+ and EDGAR and can be accessed at and respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement. Media Relations Contact: Emily Whalen Investor Relations Contact:Harrison
Yahoo
03-04-2025
- Business
- Yahoo
TSX April 2025 Spotlight: Promising Penny Stocks To Consider
As the Canadian market navigates through trade uncertainty and inflation concerns, investors are keenly observing how newly announced tariffs might impact economic growth. Amidst this backdrop, penny stocks—often representing smaller or newer companies—continue to capture attention for their potential value and growth opportunities. Despite being a somewhat outdated term, these stocks can offer affordability paired with financial strength, making them an intriguing option for those looking to explore promising investment avenues in today's market landscape. Name Share Price Market Cap Financial Health Rating Westbridge Renewable Energy (TSXV:WEB) CA$0.71 CA$68.78M ★★★★★★ Haivision Systems (TSX:HAI) CA$4.32 CA$121.88M ★★★★★☆ NTG Clarity Networks (TSXV:NCI) CA$1.82 CA$78.83M ★★★★★☆ Intermap Technologies (TSX:IMP) CA$1.87 CA$109.04M ★★★★☆☆ Orezone Gold (TSX:ORE) CA$0.92 CA$484.66M ★★★★★☆ Dynacor Group (TSX:DNG) CA$4.70 CA$201.34M ★★★★★★ PetroTal (TSX:TAL) CA$0.69 CA$613.7M ★★★★★☆ McCoy Global (TSX:MCB) CA$3.12 CA$88.33M ★★★★★★ Findev (TSXV:FDI) CA$0.48 CA$13.75M ★★★★★★ BluMetric Environmental (TSXV:BLM) CA$1.17 CA$42.83M ★★★★★★ Click here to see the full list of 923 stocks from our TSX Penny Stocks screener. Here's a peek at a few of the choices from the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Cronos Group Inc. is a cannabinoid company involved in the cultivation, production, distribution, and marketing of cannabis products across Canada, Israel, and internationally with a market cap of CA$979.28 million. Operations: The company's revenue primarily comes from the cultivation, manufacture, and marketing of cannabis and cannabis-derived products, totaling $117.62 million. Market Cap: CA$979.28M Cronos Group Inc., with a market cap of CA$979.28 million, has recently turned profitable, reporting a net income of US$41.08 million for 2024 compared to a significant loss the previous year. The company's revenue grew to US$117.62 million, driven by its cannabis operations across multiple regions. Despite low return on equity and past earnings volatility due to one-off losses, Cronos remains debt-free with strong asset coverage over liabilities. The recent appointment of Anna Shlimak as CFO could enhance strategic initiatives aimed at long-term growth and operational efficiency within the cannabis sector. Take a closer look at Cronos Group's potential here in our financial health report. Gain insights into Cronos Group's outlook and expected performance with our report on the company's earnings estimates. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Erdene Resource Development Corporation is engaged in the exploration and development of precious and base metal deposits in Mongolia, with a market cap of CA$290.21 million. Operations: Erdene Resource Development Corporation does not report distinct revenue segments. Market Cap: CA$290.21M Erdene Resource Development Corporation, with a market cap of CA$290.21 million, is pre-revenue and debt-free, focusing on precious and base metal exploration in Mongolia. The company has a seasoned management team with an average tenure of 14.2 years and an experienced board averaging 8.8 years. Despite its unprofitability and negative return on equity (-13.25%), Erdene has reduced losses by 12.8% annually over five years and maintains sufficient cash runway for over a year based on current free cash flow levels. Recent earnings reported a net loss of CA$8.25 million for 2024, contrasting with the previous year's net income. Navigate through the intricacies of Erdene Resource Development with our comprehensive balance sheet health report here. Learn about Erdene Resource Development's historical performance here. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Inventus Mining Corp. focuses on the acquisition, exploration, and development of mineral properties in Canada with a market cap of CA$16.47 million. Operations: Inventus Mining Corp. does not report any revenue segments. Market Cap: CA$16.47M Inventus Mining Corp., with a market cap of CA$16.47 million, is pre-revenue and debt-free, focusing on mineral exploration in Canada. The company has an experienced management team with an average tenure of 8.4 years and a seasoned board averaging 4.3 years. Recent drilling at the Pardo Gold Project confirmed continuity of shallow gold mineralization, indicating potential for low-cost surface mining near Sudbury, Ontario. Inventus plans further drilling to expand this resource before estimating its size formally. Despite having short-term liabilities slightly exceeding assets, the firm maintains a cash runway exceeding one year based on current free cash flow estimates. Click here and access our complete financial health analysis report to understand the dynamics of Inventus Mining. Assess Inventus Mining's previous results with our detailed historical performance reports. Click here to access our complete index of 923 TSX Penny Stocks. Ready To Venture Into Other Investment Styles? These 12 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include TSX:CRON TSX:ERD and TSXV:IVS. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
